Savvy Trades and Investments

[RNsidersbuying]

VNDA 5.06 - filed Q1 yesterday afternoon with following CC and the pps actually dipped? With this dip, VNDA is now my largest position in quite a while.

From the CC:

Mihael Polymeropoulos

...We expect several significant milestones in the coming months, including the launch of Fanapt in bipolar I disorder, the launch of PONVORY in multiple sclerosis, the potential approval of tradipitant in gastroparesis, the Phase III results of tradipitant in motion sickness, the upcoming NDA filings of milsaperidone in psychiatric disorders and tradipitant motion sickness and the initiation of clinical programs in depression, psoriasis, ulcerative colitis and pediatric insomnia.

We are confident that our robust revenue, strong cash position and efficient operations position us well for significant growth and value creation in the years to come...

https://capedge.com/transcript/1347178/2024Q1/VNDA